search
Back to results

Transcranial Electrical Stimulation in the Treatment of Acute Anxiety Induced by Stressful Life Events: A Pilot Study (OptesStressP)

Primary Purpose

Anxiety

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
NeuroConn DC Stimulator Plus tDCS
Sponsored by
University of Eastern Finland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18-65 years
  • Naïve to tDCS
  • Right-handed
  • Impact of Event Scale Scores ≥ 30

Exclusion Criteria:

  • Metal implants inside skull or eye
  • Severe skin lesions at the electrode placement area
  • History of epilepsy or previous seizures
  • Pregnant or breast-feeding
  • Pacemaker
  • History of intracerebral bleeding during the past six months
  • Major psychiatric conditions according to the Structured Clinical Interview for DSM-IV Disorders, i.e., Lifetime diagnoses of bipolar mood disorder or psychotic disorder
  • DSM-IV diagnosis for one or more of the following conditions during the past six months: unipolar mood disorder, anxiety disorders, eating disorders, or substance dependence/abuse.
  • Use of psychotropic medication (i.e., antipsychotic and antidepressant medications, mood stabilizers, psychostimulants, hypnotics and tranquilizers) during the past six months

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Treatment 1

    Treatment 2

    Arm Description

    NeuroConn DC Stimulator Plus tDCS treatment protocol no 1

    NeuroConn DC Stimulator Plus tDCS treatment protocol no 1

    Outcomes

    Primary Outcome Measures

    Impact of Event Scale (Change in scores of event-related anxiety)
    Change in scores of event-related anxiety

    Secondary Outcome Measures

    Full Information

    First Posted
    December 16, 2014
    Last Updated
    December 18, 2014
    Sponsor
    University of Eastern Finland
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02320370
    Brief Title
    Transcranial Electrical Stimulation in the Treatment of Acute Anxiety Induced by Stressful Life Events: A Pilot Study
    Acronym
    OptesStressP
    Official Title
    Optimizing Electrical Stimulation for Clinical Applications (the OptES Study): Severe Psychological Stress - a Pilot Study (OptES-Stress-pilot)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2014
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 2015 (undefined)
    Primary Completion Date
    December 2015 (Anticipated)
    Study Completion Date
    March 2016 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Eastern Finland

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The investigators examine the efficacy of two different transcranial direct current stimulation (tDCS) stimulation protocols in the treatment of acute anxiety in an open-label pilot study in patients who have faced severely stressful life events.
    Detailed Description
    Transcranial direct current stimulation (tDCS) is a novel neuromodulation method that has been observed to be promising in treatment of psychiatric disorders such as depression. Nevertheless, knowledge related to the treatment of psychological stress and its main symptom, anxiety, is very scarce. The investigators examine the efficacy of two different transcranial direct current stimulation (tDCS) stimulation protocols in the treatment of acute anxiety in an open-label pilot study in patients who have faced severely stressful life events.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Anxiety

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    14 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Treatment 1
    Arm Type
    Experimental
    Arm Description
    NeuroConn DC Stimulator Plus tDCS treatment protocol no 1
    Arm Title
    Treatment 2
    Arm Type
    Experimental
    Arm Description
    NeuroConn DC Stimulator Plus tDCS treatment protocol no 1
    Intervention Type
    Device
    Intervention Name(s)
    NeuroConn DC Stimulator Plus tDCS
    Intervention Description
    transcranial electrical stimulation intervention with two experimental protocols
    Primary Outcome Measure Information:
    Title
    Impact of Event Scale (Change in scores of event-related anxiety)
    Description
    Change in scores of event-related anxiety
    Time Frame
    12 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age 18-65 years Naïve to tDCS Right-handed Impact of Event Scale Scores ≥ 30 Exclusion Criteria: Metal implants inside skull or eye Severe skin lesions at the electrode placement area History of epilepsy or previous seizures Pregnant or breast-feeding Pacemaker History of intracerebral bleeding during the past six months Major psychiatric conditions according to the Structured Clinical Interview for DSM-IV Disorders, i.e., Lifetime diagnoses of bipolar mood disorder or psychotic disorder DSM-IV diagnosis for one or more of the following conditions during the past six months: unipolar mood disorder, anxiety disorders, eating disorders, or substance dependence/abuse. Use of psychotropic medication (i.e., antipsychotic and antidepressant medications, mood stabilizers, psychostimulants, hypnotics and tranquilizers) during the past six months
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Soili M Lehto, MD, PhD
    Phone
    +358 44 717 2971
    Email
    soili.lehto@kuh.fi
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Soili M Lehto, MD, PhD
    Organizational Affiliation
    University of Eastern Finland
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Transcranial Electrical Stimulation in the Treatment of Acute Anxiety Induced by Stressful Life Events: A Pilot Study

    We'll reach out to this number within 24 hrs